Similar articles

• Dipyrone (metamizole) use in the United States: a lethal tango?

  Moorman J. Moorman J. South Med J. 2006 Sep;99(9):916. doi: 10.1097/01.smj.0000232203.62813.3b. South Med J. 2006. PMID: 17004522 No abstract available.
• Neutropenia, agranulocytosis and dipyrone.

  Hamerschlak N, Cavalcanti AB. Hamerschlak N, et al. Sao Paulo Med J. 2005 Sep 1;123(5):247-9. doi: 10.1590/s1516-31802005000500009. Epub 2005 Dec 8. Sao Paulo Med J. 2005. PMID: 16358101 Free PMC article. Review.
• Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).

  Hedenmalm K, Spigset O. Hedenmalm K, et al. Eur J Clin Pharmacol. 2002 Jul;58(4):265-74. doi: 10.1007/s00228-002-0465-2. Epub 2002 Jun 6. Eur J Clin Pharmacol. 2002. PMID: 12136373
• Dipyrone and agranulocytosis: what is the risk?

  Schönhöfer P, Offerhaus L, Herxheimer A. Schönhöfer P, et al. Lancet. 2003 Mar 15;361(9361):968-9. doi: 10.1016/S0140-6736(03)12751-1. Lancet. 2003. PMID: 12648993 No abstract available.
• Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory Drugs.

  Konijnenbelt-Peters J, van der Heijden C, Ekhart C, Bos J, Bruhn J, Kramers C. Konijnenbelt-Peters J, et al. Pain Pract. 2017 Mar;17(3):402-408. doi: 10.1111/papr.12467. Epub 2016 Jun 27. Pain Pract. 2017. PMID: 27346584 Review.